http://orcid.org/0000-0002-3987-1589
References
- Morimoto A, Ueda Y, Egawa-Takata T, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Kanzaki H, et al. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination. Int J Clin Oncol 2015; 20(3):549-55; PMID:25001869; http://dx.doi.org/10.1007/s10147-014-0723-1
- Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother 2014; 10(9):2543-50; PMID:25483472; http://dx.doi.org/10.4161/21645515.2014.969618
- Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan's failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol 2015; 212(3):405-6; PMID:25434842; http://dx.doi.org/10.1016/j.ajog.2014.11.037
- Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet 2015; 385(9987):2571; PMID:26122153; http://dx.doi.org/10.1016/S0140-6736(15)61152-7
- Tanaka Y, Ueda Y, Egawa-Takata T, Yagi A, Yoshino K, Kimura T. Outcomes for girls without HPV vaccination in Japan. Lancet Oncol 2016; 17(7):868-9; PMID:27396634; http://dx.doi.org/10.1016/S1470-2045(16)00147-9
- Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, et al. Development of an efficient strategy to improve HPV immunization coverage in Japan. BMC Public Health 2016; 16(1):1013; PMID:27663658; http://dx.doi.org/10.1186/s12889-016-3676-7
- Van Damme P, Meijer CJ, Kieninger D, Schuyleman A, Thomas S, Luxembourg A, Baudin M. A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine 2016; 34(35):4205-12; PMID:27354258; http://dx.doi.org/10.1016/j.vaccine.2016.06.056